DoseVault
Recovery Compound

LL-37 Truncated Variants (KR-12 / KS-30)

Shorter active fragments of LL-37 (KR-12, KS-30) with retained antimicrobial activity but lower toxicity.

Scientific Overview

KR-12 (residues 18-29 of LL-37) is the smallest active fragment retaining antimicrobial activity, identified by Wang et al. (2008). KS-30 and other truncations balance efficacy with reduced cytotoxicity vs full-length LL-37. Investigated for chronic-wound, biofilm, and dental indications; no approved human indication yet.

Key Research Benefits

  • ✓Antimicrobial activity preserved
  • ✓Lower hemolysis vs full LL-37
  • ✓Wound healing research

Potential Side Effects

⚠Localized irritation (topical)
⚠Limited human trial data

Research Protocols

Common Dosages

Research

Not established
N/A

“Topical/research only”

Note: Dosages listed are common research protocols found in peer-reviewed literature and clinical trials. Individual results and requirements may vary significantly in a research context.

Dose Calculator

🧮 Peptide Reconstitution Calculator

mg

Total amount of peptide in the vial.

mL

Volume of water used to mix.

mcg

Draw to this mark

10 Units

or 0.10 mL on a U-100 syringe

Concentration:2.50 mg/mL
Peptide per Unit:25.00 mcg/unit
*Always double-check your calculations. This tool is for educational purposes only.

Explore LL-37 Truncated Variants (KR-12 / KS-30)

Where to source

Vendors with public COAs that stock this category. Affiliate links are disclosed.

  • Limitless Life Nootropics
    FL-based research-peptide supplier with Janoshik third-party COAs and a public affiliate program at ~20%.
    COA: JanoshikAffiliate disclosed
    View vendor →
  • SwissChems
    60+ peptide catalog with Janoshik COAs; weekly affiliate payouts.
    COA: JanoshikAffiliate disclosed
    View vendor →
  • Amino Club
    EU/US-facing vendor with a 20% first-order / 10% recurring affiliate model.
    COA: Third-partyAffiliate disclosed
    View vendor →

Stack LL-37 Truncated Variants (KR-12 / KS-30) with…

Curated stacking partners researched alongside LL-37 Truncated Variants (KR-12 / KS-30). Each link opens a dedicated stack page with combined benefits, side-effect overlap, and half-life considerations.

LL-37 Truncated Variants (KR-12 / KS-30) by goal

Read LL-37 Truncated Variants (KR-12 / KS-30)'s profile filtered through specific research goals.

LL-37 Truncated Variants (KR-12 / KS-30) for Muscle GainLL-37 Truncated Variants (KR-12 / KS-30) for Recovery

Molecular Profile

linear
KR-12 fragment of LL-37
12 AA Sequence

Quick Reference

Status
Research Compound
Category
Recovery
Common Dosage
Not established
N/A

Strictly for research purposes. Not for human consumption.

Related tools

Medical Disclaimer

Information provided on DoseVault is for educational and research purposes only. This website does not advocate for the human use of peptides. Peptides are currently sold as research chemicals and are not FDA-approved for human consumption. Always consult a licensed medical professional before considering any protocol.